程氏三才针法联合健脾固肾方治疗卵巢早衰的临床研究
Clinical Study on the Treatment of Premature Ovarian Failure by Cheng’s Sancai Acupuncture Combined with Jianpi Gushen Decoction
摘要: 目的：观察程氏三才针法联合中药治疗卵巢早衰(POF)的临床疗效。方法：回顾性分析2022年1月至2023年12月于柳州市人民医院就诊的400例卵巢早衰患者的临床资料，分为对照组和观察组。对照组给予常规西药联合健脾固肾方治疗，观察组在对照组基础上施以程氏三才针法。比较两组疗效、中医证候积分、不良反应发生率及性激素水平变化。结果：1) 临床疗效总有效率方面：观察组(96.0%)优于对照组(85.0%)，具有统计学差异(P < 0.05)；2) 中医证候积分方面：治疗前两组对比无明显差异(P > 0.05)；与治疗后对照组相比，观察组中医证候积分显著改善(P < 0.05)；3) 不良反应发生率方面：观察组低于对照组，差异具有统计学意义(P < 0.05)；4) 性激素水平变化方面，观察组显著高于对照组，差异具有统计学意义(P < 0.05)。结论：程氏三才针法联合中药的疗效与安全性高，可推广使用。
Abstract: Objective: To observe the clinical efficacy of Cheng’s Sancai acupuncture combined with traditional Chinese medicine in the treatment of premature ovarian failure (POF). Methods: The clinical data of 400 patients with premature ovarian failure (POF) who were admitted to Liuzhou People’s Hospital from January 2022 to December 2023 were retrospectively analyzed and divided into the control group and the observation group. The control group was treated with conventional Western medicine combined with Jianpi Gushen Decoction, and the observation group was treated with Cheng’s Sancai Acupuncture based on the control group. We compared the efficacy, TCM syndrome scores, incidence of adverse reactions, and changes in sex hormone levels between the two groups. Results: 1) Clinical efficacy of the overall efficacy rate: the observation group (96.0%) is better than the control group (85.0%), the difference is statistically significant (P < 0.05); 2) Comparison of Chinese medicine symptoms points of the two groups before treatment is not significantly different (P > 0.05); compared with the control group after the treatment, Chinese medicine symptoms points of the observation group improved significantly (P < 0.05); 3) Side effect rate: the observation group is lower than the control group, the difference is statistically significant (P < 0.05); 4) Regarding changes in sex hormone levels, the observation group was significantly higher than the control group, and the difference was statistically significant (P < 0.05). Conclusion: The efficacy and safety of Cheng’s Sancai acupuncture combined with traditional Chinese medicine are high, and can be widely used.
文章引用：刘芙蓉, 曾健, 韦婷, 盛正和, 黄艳霞, 张剑飞. 程氏三才针法联合健脾固肾方治疗卵巢早衰的临床研究[J]. 中医学, 2026, 15(4): 452-458. https://doi.org/10.12677/tcm.2026.154231

参考文献

[1] 中华中医药学会. 卵巢早衰中西医结合诊疗指南[J]. 中国中西医结合杂志, 2024, 44(10): 1167-1179.
[2] 谢幸, 孔北华, 段涛. 妇产科学[M]. 第9版. 北京: 人民卫生出版社, 2018.
[3] 任慧霞, 司帆, 朱珂, 等. 基于数据挖掘技术对中药复方治疗卵巢早衰用药规律的研究[J]. 中国中医药现代远程教育, 2022, 20(4): 45-48.
[4] Akdemir, Y., Akpolat, M., Elmas, O., Kececi, M., Buyukuysal, C., Cetinkaya, B., et al. (2022) Capsaicin Prevents Radiotherapy-Induced Premature Ovarian Failure in Rats. Reproduction, Fertility and Development, 34, 350-361. [Google Scholar] [CrossRef] [PubMed]
[5] Pargianas, M., Salta, S., Apostolopoulou, K., Lazaros, L., Kyrgiou, M., Tinelli, A., et al. (2020) Pathways Involved in Premature Ovarian Failure: A Systematic Review of Experimental Studies. Current Pharmaceutical Design, 26, 2087-2095. [Google Scholar] [CrossRef] [PubMed]
[6] 中华医学会妇产科学分会绝经学组. 早发性卵巢功能不全的临床诊疗专家共识(2023版) [J]. 中华妇产科杂志, 2023,10(58): 721-728.
[7] 谈勇. 中医妇科学[M]. 第10版. 北京: 中国中医药出版社, 2016.
[8] 郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2022.
[9] 国家中医药管理局. 中医病证诊断疗效标准[M]. 南京: 南京大学出版社, 1994.
[10] Chen, M., Li, L., Chai, Y., Yang, Y., Ma, S., Pu, X., et al. (2023) Vitamin D Can Ameliorate Premature Ovarian Failure by Inhibiting Neutrophil Extracellular Traps: A Review. Medicine, 102, e33417. [Google Scholar] [CrossRef] [PubMed]
[11] Igboeli, P., El Andaloussi, A., Sheikh, U., Takala, H., ElSharoud, A., McHugh, A., et al. (2020) Intraovarian Injection of Autologous Human Mesenchymal Stem Cells Increases Estrogen Production and Reduces Menopausal Symptoms in Women with Premature Ovarian Failure: Two Case Reports and a Review of the Literature. Journal of Medical Case Reports, 14, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[12] Aboutalebi, H., Alipour, F. and Ebrahimzadeh-Bideskan, A. (2022) The Protective Effect of Co-Administration of Platelet-Rich Plasma (PRP) and Pentoxifylline (PTX) on Cyclophosphamide-Induced Premature Ovarian Failure in Mature and Immature Rats. Toxicology Mechanisms and Methods, 32, 588-596. [Google Scholar] [CrossRef] [PubMed]
[13] 刘文钊, 陈冬梅, 陈苗, 等. 针刺联合脐带间充质干细胞改善卵巢早衰大鼠卵巢储备功能研究[J]. 北京中医药大学学报, 2023, 46(3): 435-444.
[14] Umer, A., Khan, N., Greene, D.L., Habiba, U.E., Shamim, S. and Khayam, A.U. (2022) The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure. Stem Cell Reviews and Reports, 19, 651-666. [Google Scholar] [CrossRef] [PubMed]
[15] 姜浩, 王铁云, 李海燕, 等. 腹针疗法结合程氏三才针法治疗抑郁症临床研究[J]. 新中医, 2019, 51(8): 218-220.
[16] 刘永涛, 刘美章. 程莘农院士“程氏三才针法”临床应用发微[J]. 中医药导报, 2016, 22(21): 83-84.
[17] Liu, Y., Fang, Y., Wei, J., Zhang, C., Wu, D. and Li, Y. (2022) Melatonin Protects against Primary Ovarian Insufficiency by Activating the PI3K/Akt/mTOR Pathway and Inhibiting Autophagy. Annals of Clinical and Laboratory Science, 52, 425-433.
[18] Nan, N., Du, X.L., Chen, M. and Luo, J.Q. (2023) Qirong Tablets Inhibits Apoptosis of Ovarian Granulosa Cells via PI3K/Akt/HIF-1 Signaling Pathway. Chinese Journal of Chinese Materia Medica, 48, 5311-5319.